| Pharmaceutical active ingredients: |
| Sodium Polystyrene Sulfonate |
| Available forms, composition and doses of Oligo Z: |
| N / A |
| Oligo Z medical category: |
| Human:Potassium-removing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AE01 - Polystyrene Sulfonate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Kayexalate | Sodium Polystyrene Sulfonate | Sanofi-Aventis; C.T.S. Chemical Industries; Institute of Pharmaceutical Research and Technology |
| Kexelate | Sodium Polystyrene Sulfonate | Adcock Ingram |
| K-Exit | Sodium Polystyrene Sulfonate | Omega Laboratories |
| K-Exit Poudre | Sodium Polystyrene Sulfonate | Omega Laboratories |
| Kionex | Sodium Polystyrene Sulfonate | Paddock Laboratories |
| PHL-Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Pharmel |
| PMS-Sodium Polysterene Sulfonate | Sodium Polystyrene Sulfonate | Pharmascience |
| PMS-Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Pharmascience; IDS Group |
| Resinsodio | Sodium Polystyrene Sulfonate | Rubio Laboratorios; JDH Borneo Thailand; TTN Thitiratsanon; Zyfas Medical |
| Resonium | Sodium Polystyrene Sulfonate | Sanofi-Aventis; Irex Laboratoires |